demonstrated that allogeneic DLL3 CAR T cells exhibit potent specificity and cytotoxicity against SCLC cell lines, even those with extremely low DLL3 expression (≤1000 molecules/cell), mirroring levels observed in primary tumors (41). The gene discussed is DLL3; the disease is small cell lung carcinoma.